Aktienanalyse zu Ambev SA (ABEV)ABEVAmbev SA

Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces, distributes and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company's activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala, El Salvador, Honduras, Nicaragua, Barbados and Panama; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile; and Canada, represented by Labatt’s operations, which comprises sales in Canada and some exports to the U.S. market. The Company markets products under various brand names, such as Adriatica, Brahma, Leffe, Budweiser, Corona, PepsiCo and Lipton. It is a subsidiary of Interbrew International BV. It operates in the Consumer Non-Cyclicals sector.

Ambev SA is a good buy right now due to a current price of $3.19, a strong year-to-date change of +29.15%, and a low forward P/E of 13.23, which suggests potential for growth. The stock has also shown a recent 5-day change of +6.69%, indicating positive momentum. However, the main risk is the downgrade from BofA, which cites muted earnings momentum and a tough cost outlook for 2027.